Choose your country
How GLP1Asia approaches country-specific questions
Medicine authorisation, specialist access and healthcare fees can differ across countries. Rather than assuming a prescription is available throughout Asia, each guide links to the national regulatory starting point and explains the questions a visitor should ask of a licensed provider.
We distinguish the cost of a medical screening programme from a medication price, and we do not infer product approval from marketing language or a clinic’s general weight-management page. For context on treatment classes, read our semaglutide and tirzepatide guides.